| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.23T | 9.78T | 9.73T | 10.88T | 10.26T |
| Gross Profit | 3.37T | 2.82T | 2.58T | 2.69T | 2.56T |
| EBITDA | 1.27T | 1.44T | 1.35T | 1.34T | 1.37T |
| Net Income | 850.76B | 615.72B | 589.90B | 649.12B | 583.47B |
Balance Sheet | |||||
| Total Assets | 15.11T | 13.28T | 12.22T | 12.50T | 13.89T |
| Cash, Cash Equivalents and Short-Term Investments | 1.33T | 866.24B | 1.04T | 1.18T | 1.35T |
| Total Debt | 1.01T | 1.21T | 1.18T | 2.21T | 3.13T |
| Total Liabilities | 8.30T | 7.25T | 6.36T | 7.17T | 8.53T |
| Stockholders Equity | 6.60T | 5.85T | 5.70T | 4.94T | 4.34T |
Cash Flow | |||||
| Free Cash Flow | 1.40T | 925.39B | 571.47B | 416.46B | 290.08B |
| Operating Cash Flow | 1.77T | 1.17T | 956.61B | 827.04B | 729.94B |
| Investing Cash Flow | -362.98B | -530.10B | -131.54B | 151.06B | -1.05T |
| Financing Cash Flow | -1.03T | -467.68B | -1.02T | -1.14T | 202.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $9.72B | 17.67 | 21.43% | 0.63% | 2.40% | 4.95% | |
70 Outperform | $136.74B | 31.16 | 12.91% | 0.77% | 9.11% | 34.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $137.65B | 43.68 | 23.56% | 2.24% | 1.15% | -19.00% | |
52 Neutral | $79.55B | 29.42 | 66.03% | 1.82% | 2.08% | -34.33% |